<DOC>
	<DOCNO>NCT01853384</DOCNO>
	<brief_summary>This study do find investigational product call HP802-247 help people venous leg ulcer . Investigational mean HP802-247 approve U.S. Food Drug Administration ( FDA ) . This research do compare efficacy HP802-247 plus compression therapy Vehicle plus compression therapy achieve complete wound closure 12-week treatment period . Vehicle look HP802-247 contains cell . At least 440 subject participate . The study go conduct approximately 5 country approximately 50 site across European Union .</brief_summary>
	<brief_title>Safety Efficacy Trial HP802-247 Treatment Chronic Venous Leg Ulcers</brief_title>
	<detailed_description>See Brief Summary</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Provide inform consent . Age ≥ 18 year either sex . Willing comply protocol instruction , include allow study assessment . Have venous leg ulcer ( VLU ) knee ankle ( malleolus ) , surface area ≥ 2.0 cm2 ≤ 12.0 cm2 Venous insufficiency confirm duplex Doppler ultrasound examination valvular venous incompetence . Arterial supply adequacy confirm Target ulcer involve full thickness skin loss , WITHOUT exposure tendon , muscle , bone . Target ulcer duration ≥ 6 week ≤ 104 week ( 24 month ) . Acceptable state health nutrition History anaphylaxis , serum sickness , erythema multiforme reaction aprotinin , bovine serum albumin bovine serum protein , penicillin , streptomycin , amphotericin B . Prior diagnosis Systemic Lupus Erythematosus elevate antiDNA antibody titer , Buerger 's disease ( thromboangiitis obliterans ) , current diagnosis vasculitis , current diagnosis claudication . Therapy another investigational agent within thirty ( 30 ) day Screening , study . A target ulcer nonvenous etiology ( e.g. , sickle cell anemia , necrobiosis lipoidica diabeticorum , pyoderma gangrenosum , vasculopathic vasculitic ) . Documented history osteomyelitis target wound location within 6 month precede Screening Visit . Refusal inability tolerate compression therapy . Therapy target ulcer autologous skin graft , Apligraf™ , Dermagraft™ within 30 day precede Screening Visit . History cancer precede 5 year ( carcinoma situ cervix adequately treat nonmelanoma skin cancer ) . Any prior exposure HP802247 vehicle .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>ulcer</keyword>
	<keyword>venous stasis</keyword>
	<keyword>compression</keyword>
	<keyword>venous</keyword>
	<keyword>venous stasis ulcer</keyword>
	<keyword>vlu</keyword>
	<keyword>wound</keyword>
	<keyword>varicose vein</keyword>
	<keyword>venous insufficiency</keyword>
	<keyword>dvt</keyword>
	<keyword>deep vein thrombosis</keyword>
</DOC>